ABSORB II: Comparable Clinical Outcomes Noted with ABSORB Scaffold and XIENCE Stents

Article Figures & Data

Figures

  • Figure 1.

    SAQ Exercise Performance and Angina Status

    *P value from post hoc t test; **†P value from post hoc χ2 test.SAQ, Seattle Angina Questionnaire.Reproduced from Serruys PW et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomized controlled trial. Lancet. 14 Sept 2014; In Press, Corrected Proof. Copyright 2014, with permission from Elsevier.